Cargando…
Use of digoxin-specific antibody fragments (Fab) in the management of digoxin poisoning.
Autores principales: | Brown, J. H., McLoughlin, J. C., Boland, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ulster Medical Society
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2448091/ https://www.ncbi.nlm.nih.gov/pubmed/3739069 |
Ejemplares similares
-
Chronic Digoxin Toxicity: An Evaluation of Digoxin-Specific Antibodies and Other Management Options
por: Clifford, Liam M, et al.
Publicado: (2023) -
Inappropriate use of digoxin in patients presenting with digoxin toxicity
por: Tatlisu, Mustafa Adem, et al.
Publicado: (2015) -
Digoxin-specific antibody fragments for the treatment of suspected Nerium oleander toxicosis in a cat
por: Galton, Aaron F, et al.
Publicado: (2020) -
Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study
por: Thomas, Emma, et al.
Publicado: (2023) -
Digoxin Therapy of Fetal Superior Ventricular Tachycardia: Are Digoxin Serum Levels Reliable?
por: Saad, Antonio F., et al.
Publicado: (2016)